Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enhancer Elements, Genetic | 18 | 2013 | 62 | 2.610 |
Why?
|
| Immunoglobulin Heavy Chains | 24 | 2013 | 62 | 2.580 |
Why?
|
| B-Lymphocytes | 19 | 2013 | 185 | 1.820 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 3 | 2013 | 6 | 1.180 |
Why?
|
| Genes, Immunoglobulin | 12 | 2001 | 41 | 1.170 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2013 | 49 | 0.890 |
Why?
|
| DNA-Binding Proteins | 8 | 2005 | 539 | 0.720 |
Why?
|
| Transcription Factors | 8 | 2003 | 681 | 0.700 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2013 | 18 | 0.610 |
Why?
|
| Immunoglobulins | 4 | 2011 | 37 | 0.570 |
Why?
|
| Lymphoma, T-Cell | 7 | 2003 | 28 | 0.550 |
Why?
|
| Mice | 35 | 2013 | 5913 | 0.550 |
Why?
|
| 3' Untranslated Regions | 3 | 2007 | 74 | 0.530 |
Why?
|
| T-Lymphocytes | 10 | 2005 | 357 | 0.510 |
Why?
|
| Transcription, Genetic | 11 | 2010 | 578 | 0.500 |
Why?
|
| Immunoglobulin mu-Chains | 3 | 2008 | 6 | 0.490 |
Why?
|
| Alleles | 3 | 2011 | 321 | 0.480 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2013 | 4 | 0.460 |
Why?
|
| Plasmacytoma | 8 | 2003 | 11 | 0.460 |
Why?
|
| Hybrid Cells | 9 | 2005 | 20 | 0.440 |
Why?
|
| Gene Expression Regulation | 12 | 2001 | 1015 | 0.420 |
Why?
|
| Recombination, Genetic | 3 | 2011 | 93 | 0.400 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2010 | 19 | 0.390 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 2008 | 11 | 0.380 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2007 | 807 | 0.380 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2010 | 8 | 0.380 |
Why?
|
| Animals | 35 | 2013 | 15081 | 0.370 |
Why?
|
| 3' Flanking Region | 2 | 2007 | 3 | 0.370 |
Why?
|
| Translocation, Genetic | 3 | 2007 | 42 | 0.330 |
Why?
|
| Sequence Deletion | 3 | 2011 | 87 | 0.320 |
Why?
|
| Immunoglobulin alpha-Chains | 2 | 2007 | 4 | 0.320 |
Why?
|
| Cell Fusion | 6 | 2005 | 19 | 0.310 |
Why?
|
| Immunoglobulin Constant Regions | 2 | 2007 | 2 | 0.300 |
Why?
|
| Burkitt Lymphoma | 1 | 2007 | 23 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2007 | 54 | 0.300 |
Why?
|
| Immunoglobulin A | 1 | 2007 | 58 | 0.290 |
Why?
|
| Multiple Myeloma | 4 | 1995 | 39 | 0.280 |
Why?
|
| Antibody-Producing Cells | 2 | 2001 | 6 | 0.270 |
Why?
|
| Mice, Inbred BALB C | 9 | 2003 | 661 | 0.270 |
Why?
|
| Hybridomas | 5 | 2003 | 29 | 0.260 |
Why?
|
| Trans-Activators | 2 | 2003 | 174 | 0.260 |
Why?
|
| Flow Cytometry | 3 | 2011 | 399 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 623 | 0.240 |
Why?
|
| Base Sequence | 10 | 2011 | 997 | 0.220 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 617 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 4 | 2013 | 1609 | 0.220 |
Why?
|
| Immunoglobulin gamma-Chains | 5 | 1994 | 6 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2013 | 933 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 7 | 2001 | 502 | 0.200 |
Why?
|
| Blotting, Southern | 3 | 2011 | 69 | 0.200 |
Why?
|
| Cell Line | 12 | 2001 | 1354 | 0.200 |
Why?
|
| Myeloma Proteins | 2 | 1995 | 2 | 0.190 |
Why?
|
| Immunoglobulin G | 4 | 1990 | 237 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 448 | 0.190 |
Why?
|
| Transfection | 7 | 2003 | 523 | 0.180 |
Why?
|
| Lymphoma | 3 | 1989 | 38 | 0.180 |
Why?
|
| Cells, Cultured | 3 | 2013 | 1518 | 0.170 |
Why?
|
| Spleen | 3 | 2008 | 199 | 0.170 |
Why?
|
| Octamer Transcription Factor-2 | 4 | 2003 | 7 | 0.160 |
Why?
|
| Cell Differentiation | 3 | 2013 | 587 | 0.160 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 81 | 0.160 |
Why?
|
| Chromosomes | 1 | 1998 | 37 | 0.150 |
Why?
|
| Mice, Inbred AKR | 4 | 2003 | 4 | 0.150 |
Why?
|
| RNA, Messenger | 5 | 2013 | 1207 | 0.140 |
Why?
|
| Electroporation | 1 | 1995 | 18 | 0.140 |
Why?
|
| DNA, Neoplasm | 3 | 1998 | 92 | 0.120 |
Why?
|
| Molecular Sequence Data | 6 | 1995 | 1568 | 0.120 |
Why?
|
| Immunoglobulin Fragments | 1 | 2013 | 7 | 0.120 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 2008 | 12 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 213 | 0.110 |
Why?
|
| Gene Expression | 3 | 2008 | 674 | 0.110 |
Why?
|
| DNA Primers | 2 | 2011 | 286 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 3 | 1995 | 290 | 0.110 |
Why?
|
| Transgenes | 2 | 2003 | 59 | 0.110 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1989 | 29 | 0.110 |
Why?
|
| Antigen-Presenting Cells | 2 | 1989 | 30 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 4 | 2007 | 515 | 0.110 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2011 | 14 | 0.100 |
Why?
|
| Models, Genetic | 3 | 1997 | 172 | 0.100 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 14 | 0.100 |
Why?
|
| Genes, Regulator | 2 | 1992 | 25 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 2231 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 928 | 0.090 |
Why?
|
| Immunoglobulin M | 2 | 2008 | 82 | 0.090 |
Why?
|
| Cell Separation | 1 | 2010 | 93 | 0.090 |
Why?
|
| VDJ Exons | 1 | 2008 | 1 | 0.080 |
Why?
|
| Hinge Exons | 1 | 2008 | 1 | 0.080 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2008 | 3 | 0.080 |
Why?
|
| Immunoglobulin D | 1 | 2008 | 5 | 0.080 |
Why?
|
| Cloning, Molecular | 5 | 1993 | 325 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2008 | 15 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2007 | 220 | 0.080 |
Why?
|
| Phenotype | 2 | 2003 | 689 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 132 | 0.080 |
Why?
|
| Clone Cells | 2 | 2003 | 47 | 0.080 |
Why?
|
| DNA Replication | 2 | 2005 | 152 | 0.070 |
Why?
|
| DNA | 4 | 1996 | 574 | 0.070 |
Why?
|
| Plasma Cells | 2 | 1998 | 10 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 43 | 0.060 |
Why?
|
| Introns | 3 | 2000 | 75 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2005 | 142 | 0.060 |
Why?
|
| Genes | 3 | 1984 | 60 | 0.060 |
Why?
|
| Oncogenes | 4 | 1992 | 43 | 0.060 |
Why?
|
| Chromosome Mapping | 2 | 1998 | 188 | 0.060 |
Why?
|
| Muromegalovirus | 1 | 2003 | 9 | 0.060 |
Why?
|
| Chromatin | 1 | 2005 | 169 | 0.060 |
Why?
|
| Histones | 1 | 2005 | 190 | 0.060 |
Why?
|
| Humans | 8 | 2007 | 37093 | 0.060 |
Why?
|
| Rats | 3 | 1998 | 3483 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2005 | 366 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2005 | 249 | 0.050 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2001 | 3 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 239 | 0.050 |
Why?
|
| Host Cell Factor C1 | 1 | 2001 | 5 | 0.050 |
Why?
|
| Mutation | 1 | 1986 | 1095 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2001 | 75 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2001 | 136 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 1993 | 172 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2001 | 90 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2001 | 151 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 408 | 0.050 |
Why?
|
| Plasmids | 3 | 1996 | 246 | 0.050 |
Why?
|
| Antigens, Ly | 1 | 1980 | 8 | 0.050 |
Why?
|
| Deoxyribonuclease I | 2 | 2005 | 25 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 1980 | 43 | 0.040 |
Why?
|
| Chromosome Deletion | 2 | 1993 | 56 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2001 | 308 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 448 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1998 | 22 | 0.040 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1996 | 5 | 0.040 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1996 | 13 | 0.040 |
Why?
|
| Gene Targeting | 1 | 1995 | 38 | 0.030 |
Why?
|
| CHO Cells | 1 | 1995 | 124 | 0.030 |
Why?
|
| Cricetinae | 1 | 1995 | 238 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1995 | 158 | 0.030 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1994 | 3 | 0.030 |
Why?
|
| Pentosyltransferases | 1 | 1993 | 4 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 45 | 0.030 |
Why?
|
| Methylation | 1 | 1993 | 113 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 1993 | 35 | 0.030 |
Why?
|
| Cell Survival | 1 | 1995 | 864 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 307 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1993 | 295 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 3 | 1986 | 14 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 24 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1991 | 28 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 90 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1993 | 453 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1990 | 150 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 1989 | 18 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1986 | 69 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1989 | 47 | 0.020 |
Why?
|
| Epitopes | 1 | 1989 | 148 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1989 | 89 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 2000 | 59 | 0.020 |
Why?
|
| Chloroquine | 1 | 1988 | 19 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1988 | 116 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1988 | 515 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2005 | 25 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 53 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2005 | 37 | 0.020 |
Why?
|
| Locus Control Region | 1 | 2005 | 8 | 0.020 |
Why?
|
| Acetylation | 1 | 2005 | 98 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 1983 | 21 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1982 | 167 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1983 | 387 | 0.010 |
Why?
|
| Immune Sera | 1 | 2000 | 59 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2000 | 72 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 1980 | 20 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1980 | 79 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2000 | 177 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2000 | 236 | 0.010 |
Why?
|
| TCF Transcription Factors | 1 | 1996 | 15 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1996 | 272 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 651 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 31 | 0.010 |
Why?
|
| Testis | 1 | 1992 | 187 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 1180 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1984 | 10 | 0.000 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1984 | 9 | 0.000 |
Why?
|
| Endonucleases | 1 | 1984 | 20 | 0.000 |
Why?
|
| Male | 1 | 1992 | 20025 | 0.000 |
Why?
|